<html>
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
  </head>
  <body text="#000000" bgcolor="#FFFFFF">
    <p>Hi All,  <br>
    </p>
    <p>To borrow and modify a phrase from Anne -- please keep in mind
      that that was absolutely nothing in the 2012 AGB that provided for
      .BRAND protection (Specification 13 dates back to special action
      by the Board in 2014).</p>
    <p>In response to widespread calls, we clarified that Closed
      Generics would be banned and created a balance in allowing .BRANDS
      to be closed.  I am assuming that all of this post-2012 work is
      being put up for review and re-evalaution...</p>
    <p>Best, Kathy<br>
    </p>
    <p>On 8/28/2019 3:51 PM, Aikman-Scalese, Anne wrote:</p>
    <blockquote type="cite"
      cite="mid:e5e45c25214741b9be1cd51a11864df3@lrrc.com">
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <meta name="Generator" content="Microsoft Word 15 (filtered
        medium)">
      <!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]-->
      <style><!--
/* Font Definitions */
@font-face
        {font-family:Helvetica;
        panose-1:2 11 6 4 2 2 2 2 2 4;}
@font-face
        {font-family:"Cambria Math";
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Consolas;
        panose-1:2 11 6 9 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0in;
        margin-bottom:.0001pt;
        font-size:12.0pt;
        font-family:"Times New Roman",serif;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
pre
        {mso-style-priority:99;
        mso-style-link:"HTML Preformatted Char";
        margin:0in;
        margin-bottom:.0001pt;
        font-size:10.0pt;
        font-family:"Courier New";}
span.HTMLPreformattedChar
        {mso-style-name:"HTML Preformatted Char";
        mso-style-priority:99;
        mso-style-link:"HTML Preformatted";
        font-family:Consolas;}
p.msonormal0, li.msonormal0, div.msonormal0
        {mso-style-name:msonormal;
        mso-margin-top-alt:auto;
        margin-right:0in;
        mso-margin-bottom-alt:auto;
        margin-left:0in;
        font-size:12.0pt;
        font-family:"Times New Roman",serif;}
span.EmailStyle20
        {mso-style-type:personal-reply;
        color:#1F497D;}
.MsoChpDefault
        {mso-style-type:export-only;
        font-size:10.0pt;
        font-family:"Calibri",sans-serif;}
@page WordSection1
        {size:8.5in 11.0in;
        margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
      <div class="WordSection1">
        <p class="MsoNormal"><span style="color:#1F497D">Hi Heather,<o:p></o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D">There is no
            prohibition on a registry seeking a reasonable contract
            modification from ICANN in light of all circumstances.  
            It’s codified in Consensus Policy as the
            <b>RSEP </b>process.   An unreasonable denial of that RSEP
            request for contract modification is fertile ground for a
            Request for Reconsideration, Independent Review Process, all
            the way up to and including a lawsuit. 
            <o:p></o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D">See  <a
              href="https://www.icann.org/resources/pages/rsep-2014-02-19-en"
              moz-do-not-send="true">
              https://www.icann.org/resources/pages/rsep-2014-02-19-en</a> 
            and note the legitimate purpose to “modify” or “remove” an
            existing Registry service.<o:p></o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D">Let’s take the
            real life example of .BEAUTY – originally proposed as closed
            –now delegated as “open” and NOT launched (at least
            according to ICANN Sunrise records at the link provided by
            Rubens and I don’t see anything at <a
              href="http://www.nic.beauty" moz-do-not-send="true">www.nic.beauty</a>. 
             Are we really saying that if L’Oreal’s competitor applies
            for and gets .PRETTY as a Closed Generic based on a 2022
            application, it doesn’t matter and L’Oreal is stuck with
            remaining an open generic even if they have not launched? 
            (I don’t represent L’Oreal or any other beauty industry
            client.)  Keep in mind that there was absolutely nothing in
            the 2012 AGB that prohibited an application for a Closed
            Generic.  (Sounds vaguely familiar to another IRP
            proceeding.)<o:p></o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D">Maybe out of
            scope for Sub Pro, but GNSO Council will have to deal with
            this if they don’t want a “logjam” at the Board level as to
            any new Closed Generic policy that may be developed. 
            <o:p></o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D">Anne<o:p></o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><span style="color:#1F497D"><o:p> </o:p></span></p>
        <p class="MsoNormal"><b><span
              style="font-size:11.0pt;font-family:"Calibri",sans-serif">From:</span></b><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">
            Heather Forrest <</span><a
            href="mailto:haforrestesq@gmail.com" moz-do-not-send="true"><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">haforrestesq@gmail.com</span></a><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">>
            <br>
            <b>Sent:</b> Tuesday, August 27, 2019 8:44 PM<br>
            <b>To:</b> Maxim Alzoba <</span><a
            href="mailto:m.alzoba@gmail.com" moz-do-not-send="true"><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">m.alzoba@gmail.com</span></a><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">><br>
            <b>Cc:</b> Aikman-Scalese, Anne <</span><a
            href="mailto:AAikman@lrrc.com" moz-do-not-send="true"><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">AAikman@lrrc.com</span></a><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif">>;
          </span><a href="mailto:gnso-newgtld-wg@icann.org"
            moz-do-not-send="true"><span
              style="font-size:11.0pt;font-family:"Calibri",sans-serif">gnso-newgtld-wg@icann.org</span></a><span
style="font-size:11.0pt;font-family:"Calibri",sans-serif"><br>
            <b>Subject:</b> Re: [Gnso-newgtld-wg] Closed Generics and
            the 2012 Round<o:p></o:p></span></p>
        <p class="MsoNormal"><o:p> </o:p></p>
        <div>
          <div>
            <p class="MsoNormal"><strong><span
style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:black">[EXTERNAL]</span></strong><span
style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:black"><o:p></o:p></span></p>
            <div class="MsoNormal" style="text-align:center"
              align="center">
              <hr width="100%" size="2" align="center">
            </div>
          </div>
          <p class="MsoNormal">Thanks, Maxim - I understand that, but
            amendments to an in-force contract are not the same as
            repudiating a contract and asking for a new contract to
            apply. The terms of the RA (clause 7.6(a) re "Special
            Amendment") and the AGB expressly provided for amendments to
            both.<o:p></o:p></p>
          <div>
            <div>
              <div>
                <p class="MsoNormal"><o:p> </o:p></p>
              </div>
              <div>
                <p class="MsoNormal">AGB Module 6, cl 14: "ICANN
                  reserves the right to make reasonable updates and
                  changes to this applicant guidebook and to the
                  application process, including the process for
                  withdrawal of applications, at any time by posting
                  notice of such updates and changes to the ICANN
                  website, including as the possible result of new
                  policies that might be adopted or advice to ICANN from
                  ICANN advisory committees during the course of the
                  application process.  Applicant acknowledges that
                  ICANN may make such updates and changes and agrees
                  that its application will be subject to any such
                  updates and changes. In the event that Applicant has
                  completed and submitted its application prior to such
                  updates or changes and Applicant can demonstrate to
                  ICANN that compliance with such updates or changes
                  would present a material hardship to Applicant, then
                  ICANN will work with Applicant in good faith to
                  attempt to make reasonable accommodations in order to
                  mitigate any negative consequences for Applicant to
                  the extent possible consistent with ICANN's mission to
                  ensure the stable and secure operation of the
                  Internet's unique identifier systems." <o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal"><o:p> </o:p></p>
              </div>
              <div>
                <p class="MsoNormal">I can anticipate here that someone
                  will say: "But Module 6 cl 14 expressly anticipates
                  changes to the AGB and gives the 2012 applicant a
                  right to demonstrate material hardship caused by the
                  'new' AGB being on more favourable terms!" I don't
                  think that will be consistent with standard contract
                  law interpretation in US courts, as only the 2012
                  applicants agreed to be contractually bound by the
                  2012 AGB, while new round applicants will only have
                  the option of agreeing to whatever the AGB (or
                  whatever name it has) is at that time, not a choice
                  between old AGB or new AGB. A strict interpretation of
                  "changes to
                  <i>this applicant guidebook</i>" logically suggests
                  that the 2012 AGB binds applicants who applied in
                  2012, because by applying, they consented to the
                  application of the 2012 AGB. A new AGB, even if
                  technically an amended version of the prior document,
                  would apply to new applicants in the "next" round,
                  whenever that is. Articulated another way, I think
                  Jeff's point to now is that the charter of SubPro PDP
                  instructs us to develop the rules that will apply to
                  applicants in this "next" round, not to unsuccessful
                  or any other applicants of the 2012 round (who already
                  contractually agreed to a set of rules when they
                  submitted their application to the TAS). The question
                  of whether the new AGB/RA that results from SubPro
                  PDP, RPM PDP, CCT Review, etc is to be applied to 2012
                  applicants is not within our PDP's scope. That's the
                  question that would have to go to Council.<o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal"><o:p> </o:p></p>
              </div>
              <div>
                <p class="MsoNormal">Best wishes,<o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal"><o:p> </o:p></p>
              </div>
              <div>
                <p class="MsoNormal">Heather<o:p></o:p></p>
                <div>
                  <p class="MsoNormal"><o:p> </o:p></p>
                </div>
                <div>
                  <p class="MsoNormal">.<o:p></o:p></p>
                  <div>
                    <p class="MsoNormal"><o:p> </o:p></p>
                  </div>
                  <div>
                    <p class="MsoNormal">Best wishes,<o:p></o:p></p>
                  </div>
                  <div>
                    <p class="MsoNormal"><o:p> </o:p></p>
                  </div>
                  <div>
                    <p class="MsoNormal">Heather<o:p></o:p></p>
                  </div>
                </div>
              </div>
            </div>
          </div>
        </div>
        <p class="MsoNormal"><o:p> </o:p></p>
        <div>
          <div>
            <p class="MsoNormal">On Wed, Aug 28, 2019 at 11:51 AM Maxim
              Alzoba <<a href="mailto:m.alzoba@gmail.com"
                moz-do-not-send="true">m.alzoba@gmail.com</a>> wrote:<o:p></o:p></p>
          </div>
          <blockquote style="border:none;border-left:solid #CCCCCC
            1.0pt;padding:0in 0in 0in
6.0pt;margin-left:4.8pt;margin-top:5.0pt;margin-right:0in;margin-bottom:5.0pt">
            <div>
              <div>
                <p class="MsoNormal" style="margin-bottom:12.0pt">Heather,
                  <o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal" style="margin-bottom:12.0pt">Formally
                  ICANN changed AGB and RAin 2012 (Pic spec, for
                  example), after the fees were paid.
                  <o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal" style="margin-bottom:12.0pt">But
                  anyway, we should not mix rules from the different
                  sets.
                  <o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal">Maxim Alzoba<o:p></o:p></p>
              </div>
              <div>
                <p class="MsoNormal">On 28 Aug 2019, at 08:35, Heather
                  Forrest <<a href="mailto:haforrestesq@gmail.com"
                    target="_blank" moz-do-not-send="true">haforrestesq@gmail.com</a>>
                  wrote:<o:p></o:p></p>
                <blockquote style="border:none;border-left:solid #CCCCCC
                  1.0pt;padding:0in 0in 0in
6.0pt;margin-left:4.8pt;margin-top:5.0pt;margin-right:0in;margin-bottom:5.0pt">
                  <div>
                    <p class="MsoNormal">Anne, all,<o:p></o:p></p>
                    <div>
                      <p class="MsoNormal"><o:p> </o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal">It seems to me that basic
                        principles of contract law apply here to keep us
                        out of the weeds. ICANN's legal framework
                        depends, in its entirety, on contract after all.
                        Applicants who applied in 2012 under the AGB
                        contractually agreed, by submitting an
                        application, to the AGB and the base RA that was
                        incorporated in it. Those applicants did not
                        apply under a future AGB, or a future RA to
                        reflect that future AGB. <o:p></o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal"><o:p> </o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal">Whether a party on a 2012-era
                        contract can adopt (in the case of those not yet
                        contracted) the new RA or rescind current RA and
                        adopt new RA (for those already completed
                        contracting) is a separate question. I agree
                        with Jeff that this separate question is not
                        within the scope of the SubPro charter.<o:p></o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal"><o:p> </o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal">Best wishes,<o:p></o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal"><o:p> </o:p></p>
                    </div>
                    <div>
                      <p class="MsoNormal">Heather<o:p></o:p></p>
                    </div>
                  </div>
                  <p class="MsoNormal"><o:p> </o:p></p>
                  <div>
                    <div>
                      <p class="MsoNormal">On Tue, Aug 27, 2019 at 5:50
                        AM Aikman-Scalese, Anne <<a
                          href="mailto:AAikman@lrrc.com" target="_blank"
                          moz-do-not-send="true">AAikman@lrrc.com</a>>
                        wrote:<o:p></o:p></p>
                    </div>
                    <blockquote style="border:none;border-left:solid
                      #CCCCCC 1.0pt;padding:0in 0in 0in
6.0pt;margin-left:4.8pt;margin-top:5.0pt;margin-right:0in;margin-bottom:5.0pt">
                      <div>
                        <div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#993366">Hi Jeff – Do we have
                              Susan’s draft language on your first point
                              yet?  (You may recall that there were even
                              discussions about PROHIBITING new
                              applications for the same string as some
                              still pending from 2012 –that was not
                              agreed so Susan is working on a statement
                              that 2012 string application processing
                              must be complete before any new
                              application for that string would be
                              considered.  HOWEVER – again here is the
                              “rub” – When you say 2012 string
                              applications have to be “completed”, what
                              are you saying about the policy that
                              applies to those?    What if the pending
                              strings from 2012 don’t meet current new
                              gTLD policy but they did not violate that
                              policy as of the time of application?  We
                              can only skirt this issue for so long. 
                              Are 2012 strings going to be allowed to
                              update to current gTLD policy in order to
                              get authorization to proceed or not?  Or
                              are you saying GNSO Council will have to
                              launch another PDP for that purpose?</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#993366"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
                                style="font-size:11.0pt">From:</span></b><span
                              style="font-size:11.0pt"> Jeff Neuman <</span><a
                              href="mailto:jeff.neuman@comlaude.com"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">jeff.neuman@comlaude.com</span></a><span
                              style="font-size:11.0pt">>
                              <br>
                              <b>Sent:</b> Monday, August 26, 2019 12:43
                              PM<br>
                              <b>To:</b> Aikman-Scalese, Anne <</span><a
                              href="mailto:AAikman@lrrc.com"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">AAikman@lrrc.com</span></a><span
                              style="font-size:11.0pt">>;
                            </span><a
                              href="mailto:gnso-newgtld-wg@icann.org"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">gnso-newgtld-wg@icann.org</span></a><span
                              style="font-size:11.0pt"><br>
                              <b>Subject:</b> RE: Closed Generics and
                              the 2012 Round</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"> <o:p></o:p></p>
                          <div>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><strong><span
style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:black">[EXTERNAL]</span></strong><o:p></o:p></p>
                            <div class="MsoNormal"
                              style="text-align:center" align="center">
                              <hr width="100%" size="2" align="center">
                            </div>
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">Anne,</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">Where has it been
                              proposed that applications from 2012 get
                              priority?  I am not aware of any
                              recommendation that we have made that
                              gives “priority” to any applicants from
                              2012.  We did recommend that any
                              applications that were still outstanding
                              for a string that is applied from in a
                              subsequent round be completed. 
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">With respect to
                              Exclusive Generics, the Board resolution
                              on this matter stated that any
                              applications that wanted to maintain their
                              “exclusive generic” status would be
                              “deferred to the next round of the New
                              gTLD Program, subject to rules developed
                              for the next round…”   They did not state
                              that any of those applications would get
                              priority.  However, there were no
                              applications that were deferred from the
                              last round.</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">If we did allow
                              some form of Exclusive Generic in the next
                              round, then those rules would only apply
                              to new applicants for TLDs.  Discussing
                              what happens to TLDs from 2012 that wanted
                              to be Exclusive Generics, but ended up
                              opening their TLDs because of the Board
                              Resolution is not within the topics
                              contained within our Charter.  So yes if
                              we wanted to discuss that issue we would
                              need an amendment to our charter to allow
                              us to tackle that subject.  The GNSO could
                              then either grant our request or farm that
                              issue out to a separate group.  That is
                              within their discretion. 
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">This is no
                              different than any other changes we
                              recommend where applicants from the past
                              round would want the same things.  For
                              example, if we accept changes to the code
                              of conduct, the COI, reserved names,
                              agreement, etc., the existing registries
                              would not get the benefit of those changes
                              unless the changes go through a PDP that
                              has jurisdiction over those issues.   All
                              Applications / TLDs are treated according
                              the to rules for the round in which they
                              applied.  This is true regardless of
                              whether they have launched yet or not.</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">I hope this
                              clears things up.</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <div>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                  lang="EN-GB">Jeff Neuman</span></b><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">Senior Vice President </span><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                  lang="EN-GB">Com Laude | Valideus</span></b><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">D: +1.703.635.7514</span><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">E:
                              </span><a
                                href="mailto:jeff.neuman@comlaude.com"
                                target="_blank" moz-do-not-send="true"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif"
                                  lang="EN-GB">jeff.neuman@comlaude.com</span></a><o:p></o:p></p>
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <div>
                            <div style="border:none;border-top:solid
                              #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
                              <p class="MsoNormal"
                                style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
                                    style="font-size:11.0pt">From:</span></b><span
                                  style="font-size:11.0pt">
                                  Aikman-Scalese, Anne <</span><a
                                  href="mailto:AAikman@lrrc.com"
                                  target="_blank" moz-do-not-send="true"><span
                                    style="font-size:11.0pt">AAikman@lrrc.com</span></a><span
                                  style="font-size:11.0pt">>
                                  <br>
                                  <b>Sent:</b> Monday, August 26, 2019
                                  2:55 PM<br>
                                  <b>To:</b> Jeff Neuman <</span><a
                                  href="mailto:jeff.neuman@comlaude.com"
                                  target="_blank" moz-do-not-send="true"><span
                                    style="font-size:11.0pt">jeff.neuman@comlaude.com</span></a><span
                                  style="font-size:11.0pt">>;
                                </span><a
                                  href="mailto:gnso-newgtld-wg@icann.org"
                                  target="_blank" moz-do-not-send="true"><span
                                    style="font-size:11.0pt">gnso-newgtld-wg@icann.org</span></a><span
                                  style="font-size:11.0pt"><br>
                                  <b>Subject:</b> RE: Closed Generics
                                  and the 2012 Round</span><o:p></o:p></p>
                            </div>
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"> <o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#1F497D">Thanks Jeff.  Your
                              reasoning below is not consistent with
                              what has been proposed in relation to
                              giving priority to applications from the
                              2012 round that have not been withdrawn. 
                              (How is it that this “priority” is in
                              scope for our WG but nothing else re 2012
                              applicants is in scope?   AND if I applied
                              for a Closed Generic and didn’t get it in
                              2012, why should I have to require another
                              PDP authorization from GNSO Council in
                              order to be treated similarly to new
                              applicants and convert to a Closed
                              Generic?  (I believe some open registries
                              that won contention sets in 2012 may not
                              have not have actually launched yet.  Why
                              would we say that whether or not they can
                              launch as a Closed Generic is up to GNSO
                              Council?)</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#1F497D">Thank you,</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#1F497D">Anne</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#1F497D"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="color:#1F497D"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
                                style="font-size:11.0pt">From:</span></b><span
                              style="font-size:11.0pt"> Gnso-newgtld-wg
                              <</span><a
                              href="mailto:gnso-newgtld-wg-bounces@icann.org"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">gnso-newgtld-wg-bounces@icann.org</span></a><span
                              style="font-size:11.0pt">>
                              <b>On Behalf Of </b>Jeff Neuman<br>
                              <b>Sent:</b> Monday, August 26, 2019 5:27
                              AM<br>
                              <b>To:</b> Jeff Neuman <</span><a
                              href="mailto:jeff.neuman@comlaude.com"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">jeff.neuman@comlaude.com</span></a><span
                              style="font-size:11.0pt">>;
                            </span><a
                              href="mailto:gnso-newgtld-wg@icann.org"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">gnso-newgtld-wg@icann.org</span></a><span
                              style="font-size:11.0pt"><br>
                              <b>Subject:</b> Re: [Gnso-newgtld-wg]
                              Closed Generics and the 2012 Round</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"> <o:p></o:p></p>
                          <div>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><strong><span
style="font-size:9.0pt;font-family:"Helvetica",sans-serif;color:black">[EXTERNAL]</span></strong><o:p></o:p></p>
                            <div class="MsoNormal"
                              style="text-align:center" align="center">
                              <hr width="100%" size="1" align="center">
                            </div>
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">Thanks all.  We
                              have already got a number of people signed
                              up for the group.  I expect substantive
                              discussions on this topic to start this
                              week.  So, it is not too late to join. 
                              But remember that if you join, the
                              expectation is that we will attempt to
                              find a compromise solution that we all can
                              live with (if possible).</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">You can view the
                              member list for the small group here: 
                            </span><a
href="https://community.icann.org/display/NGSPP/Members+New+gTLD+%3A+Topic+of+Closed+Generics"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">https://community.icann.org/display/NGSPP/Members+New+gTLD+%3A+Topic+of+Closed+Generics</span></a><span
                              style="font-size:11.0pt">  Please allow a
                              day or two to pass before seeing your name
                              on the list if you just volunteered over
                              the weekend or today. 
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">We will not be
                              talking about Closed Generics in our next
                              meeting tomorrow (late tonight for some of
                              us).</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <div>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                  lang="EN-GB">Jeff Neuman</span></b><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">Senior Vice President </span><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                  lang="EN-GB">Com Laude | Valideus</span></b><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">D: +1.703.635.7514</span><o:p></o:p></p>
                            <p class="MsoNormal"
                              style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">E:
                              </span><a
                                href="mailto:jeff.neuman@comlaude.com"
                                target="_blank" moz-do-not-send="true"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif"
                                  lang="EN-GB">jeff.neuman@comlaude.com</span></a><o:p></o:p></p>
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <div>
                            <div style="border:none;border-top:solid
                              #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in">
                              <p class="MsoNormal"
                                style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
                                    style="font-size:11.0pt">From:</span></b><span
                                  style="font-size:11.0pt">
                                  Gnso-newgtld-wg <</span><a
                                  href="mailto:gnso-newgtld-wg-bounces@icann.org"
                                  target="_blank" moz-do-not-send="true"><span
                                    style="font-size:11.0pt">gnso-newgtld-wg-bounces@icann.org</span></a><span
                                  style="font-size:11.0pt">>
                                  <b>On Behalf Of </b>Jeff Neuman<br>
                                  <b>Sent:</b> Friday, August 23, 2019
                                  11:01 AM<br>
                                  <b>To:</b> </span><a
                                  href="mailto:gnso-newgtld-wg@icann.org"
                                  target="_blank" moz-do-not-send="true"><span
                                    style="font-size:11.0pt">gnso-newgtld-wg@icann.org</span></a><span
                                  style="font-size:11.0pt"><br>
                                  <b>Subject:</b> [Gnso-newgtld-wg]
                                  Closed Generics and the 2012 Round</span><o:p></o:p></p>
                            </div>
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">All,</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"><br>
                              There has been a lot of discussion in the
                              past 24 hours or so on the applicability
                              of our work on the 2012 applications. 
                              Some have expressed concerns about the
                              “fairness” of establishing a policy or new
                              procedures for subsequent rounds when
                              Closed Generics were not allowed in 2012. 
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">The applicable
                              Board Resolution covering Closed Generics
                              required the 2012 applicants for Closed
                              Generics to do one of three things. 
                              Applicants could have withdrawn their
                              applications completely, signed the
                              then-current Registry Agreement which did
                              not allow Closed Generics, or could have
                              deferred their applications for
                              consideration in a subsequent round.   As
                              we covered on the call on Thursday, all of
                              the applicants chose either to convert
                              their applications to open TLDs or
                              withdraw their applications completely. 
                              There were NO applicants that elected to
                              defer their applications to any future
                              round.   </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">Therefore,
                              although in theory we could have had some
                              issues that we needed to address involving
                              applicants in the 2012 round, the reality
                              is that we do not have any such issues. 
                              To address the arguments about fairness of
                              any new policy recommendations on
                              applicants from the previous round, all we
                              can say is that we need to focus on what
                              the right policy should be first without
                              the consideration of the fairness or
                              unfairness to previous applicants from
                              having different rules.  If we as a group
                              determine that the right policy is
                              something other than what happened in
                              2012, then it will by up to the GNSO
                              Council to either set up a new group to
                              deal with that issue or to refer the issue
                              to this group at a later date.  But for
                              now, as some have stated, that issue is
                              out of scope for our group. 
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">The reality is
                              that there are many things that this group
                              is considering which could produce results
                              that may treat new applicants differently
                              than previous round applicants.  Some of
                              those changes may be favorable to the new
                              applicants and some less favorable.  The
                              same is true with respect to previous
                              applicants.  If we did not make any
                              changes to policy or implementation for
                              fear of the impact on previous or new
                              applicants, no changes would ever be
                              made.  The point is that we need to decide
                              what is the right thing to do, point out
                              to the GNSO Council the potential impacts,
                              and then leave it to the Council on what
                              the next steps should be.</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">Finally, all
                              requests for data or information from
                              ICANN staff or any outside third party
                              should go through the Working Group
                              Leadership team. No working group members
                              should request information directly
                              without Leadership’s review. Leadership
                              reviews all outstanding action items,
                              including requests for information, and
                              makes a decision on what is necessary and
                              what is feasible.  We consider all of
                              these requests seriously and weigh the
                              pros and cons of getting that data,
                              including time, resources and cost.</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"><br>
                              Thanks for your cooperation and let us
                              know if you have any comments or
                              questions. 
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">Jeff Neuman</span></b><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB">Senior Vice President </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB"> </span></b><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                                lang="EN-GB">Com Laude | Valideus<br>
                              </span></b><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB">1751 Pinnacle Drive
                            </span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB">Suite 600, McLean</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB">VA 22102, USA</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB"><br>
                              M: +1.202.549.5079</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB">D: +1.703.635.7514</span><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB">E:
                            </span><a
                              href="mailto:jeff.neuman@comlaude.com"
                              target="_blank" moz-do-not-send="true"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif"
                                lang="EN-GB">jeff.neuman@comlaude.com</span></a><span
style="font-size:9.0pt;font-family:"Arial",sans-serif;color:black"
                              lang="EN-GB"><br>
                            </span><a href="http://www.comlaude.com/"
                              target="_blank" moz-do-not-send="true"><span
style="font-size:9.0pt;font-family:"Arial",sans-serif"
                                lang="EN-GB">www.comlaude.com</span></a><o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><o:p> </o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <div class="MsoNormal"
                            style="text-align:center" align="center"><span
                              style="font-size:11.0pt">
                              <hr width="100%" size="1" align="center">
                            </span></div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt">The contents of
                              this email and any attachments are
                              confidential to the intended recipient.
                              They may not be disclosed, used by or
                              copied in any way by anyone other than the
                              intended recipient. If you have received
                              this message in error, please return it to
                              the sender (deleting the body of the email
                              and attachments in your reply) and
                              immediately and permanently delete it.
                              Please note that the Com Laude Group does
                              not accept any responsibility for viruses
                              and it is your responsibility to scan or
                              otherwise check this email and any
                              attachments. The Com Laude Group does not
                              accept liability for statements which are
                              clearly the sender's own and not made on
                              behalf of the group or one of its member
                              entities. The Com Laude Group includes
                              Nom-IQ Limited t/a Com Laude, a company
                              registered in England and Wales with
                              company number 5047655 and registered
                              office at 28-30 Little Russell Street,
                              London, WC1A 2HN England; Valideus
                              Limited, a company registered in England
                              and Wales with company number 06181291 and
                              registered office at 28-30 Little Russell
                              Street, London, WC1A 2HN England; Demys
                              Limited, a company registered in Scotland
                              with company number SC197176, having its
                              registered office at 33 Melville Street,
                              Edinburgh, Lothian, EH3 7JF Scotland;
                              Consonum, Inc. dba Com Laude USA and
                              Valideus USA, headquartered at 1751
                              Pinnacle Drive, Suite 600, McLean, VA
                              22102, USA; Com Laude (Japan) Corporation,
                              a company registered in Japan having its
                              registered office at Suite 319,1-3-21
                              Shinkawa, Chuo-ku, Tokyo, 104-0033, Japan.
                              For further information see
                            </span><a href="https://comlaude.com"
                              target="_blank" moz-do-not-send="true"><span
                                style="font-size:11.0pt">www.comlaude.com</span></a><span
                              style="font-size:11.0pt">
                            </span><o:p></o:p></p>
                          <div class="MsoNormal"
                            style="text-align:center" align="center">
                            <hr width="100%" size="1" align="center">
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto">The
                            contents of this email and any attachments
                            are confidential to the intended recipient.
                            They may not be disclosed, used by or copied
                            in any way by anyone other than the intended
                            recipient. If you have received this message
                            in error, please return it to the sender
                            (deleting the body of the email and
                            attachments in your reply) and immediately
                            and permanently delete it. Please note that
                            the Com Laude Group does not accept any
                            responsibility for viruses and it is your
                            responsibility to scan or otherwise check
                            this email and any attachments. The Com
                            Laude Group does not accept liability for
                            statements which are clearly the sender's
                            own and not made on behalf of the group or
                            one of its member entities. The Com Laude
                            Group includes Nom-IQ Limited t/a Com Laude,
                            a company registered in England and Wales
                            with company number 5047655 and registered
                            office at 28-30 Little Russell Street,
                            London, WC1A 2HN England; Valideus Limited,
                            a company registered in England and Wales
                            with company number 06181291 and registered
                            office at 28-30 Little Russell Street,
                            London, WC1A 2HN England; Demys Limited, a
                            company registered in Scotland with company
                            number SC197176, having its registered
                            office at 33 Melville Street, Edinburgh,
                            Lothian, EH3 7JF Scotland; Consonum, Inc.
                            dba Com Laude USA and Valideus USA,
                            headquartered at 1751 Pinnacle Drive, Suite
                            600, McLean, VA 22102, USA; Com Laude
                            (Japan) Corporation, a company registered in
                            Japan having its registered office at Suite
                            319,1-3-21 Shinkawa, Chuo-ku, Tokyo,
                            104-0033, Japan. For further information see
                            <a href="https://comlaude.com"
                              target="_blank" moz-do-not-send="true">
                              www.comlaude.com</a> <o:p></o:p></p>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
                              style="font-size:11.0pt"> </span><o:p></o:p></p>
                          <div class="MsoNormal"
                            style="text-align:center" align="center"><span
                              style="font-size:11.0pt">
                              <hr width="100%" size="2" align="center">
                            </span></div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto"><span
style="font-size:7.5pt;font-family:"Arial",sans-serif;color:gray"><br>
                              This message and any attachments are
                              intended only for the use of the
                              individual or entity to which they are
                              addressed. If the reader of this message
                              or an attachment is not the intended
                              recipient or the employee or agent
                              responsible for delivering the message or
                              attachment to the intended recipient you
                              are hereby notified that any
                              dissemination, distribution or copying of
                              this message or any attachment is strictly
                              prohibited. If you have received this
                              communication in error, please notify us
                              immediately by replying to the sender. The
                              information transmitted in this message
                              and any attachments may be privileged, is
                              intended only for the personal and
                              confidential use of the intended
                              recipients, and is covered by the
                              Electronic Communications Privacy Act, 18
                              U.S.C. §2510-2521.
                            </span><o:p></o:p></p>
                          <div class="MsoNormal"
                            style="text-align:center" align="center">
                            <hr width="100%" size="2" align="center">
                          </div>
                          <p class="MsoNormal"
                            style="mso-margin-top-alt:auto;mso-margin-bottom-alt:auto">The
                            contents of this email and any attachments
                            are confidential to the intended recipient.
                            They may not be disclosed, used by or copied
                            in any way by anyone other than the intended
                            recipient. If you have received this message
                            in error, please return it to the sender
                            (deleting the body of the email and
                            attachments in your reply) and immediately
                            and permanently delete it. Please note that
                            the Com Laude Group does not accept any
                            responsibility for viruses and it is your
                            responsibility to scan or otherwise check
                            this email and any attachments. The Com
                            Laude Group does not accept liability for
                            statements which are clearly the sender's
                            own and not made on behalf of the group or
                            one of its member entities. The Com Laude
                            Group includes Nom-IQ Limited t/a Com Laude,
                            a company registered in England and Wales
                            with company number 5047655 and registered
                            office at 28-30 Little Russell Street,
                            London, WC1A 2HN England; Valideus Limited,
                            a company registered in England and Wales
                            with company number 06181291 and registered
                            office at 28-30 Little Russell Street,
                            London, WC1A 2HN England; Demys Limited, a
                            company registered in Scotland with company
                            number SC197176, having its registered
                            office at 33 Melville Street, Edinburgh,
                            Lothian, EH3 7JF Scotland; Consonum, Inc.
                            dba Com Laude USA and Valideus USA,
                            headquartered at 1751 Pinnacle Drive, Suite
                            600, McLean, VA 22102, USA; Com Laude
                            (Japan) Corporation, a company registered in
                            Japan having its registered office at Suite
                            319,1-3-21 Shinkawa, Chuo-ku, Tokyo,
                            104-0033, Japan. For further information see
                            <a href="https://comlaude.com"
                              target="_blank" moz-do-not-send="true">
                              www.comlaude.com</a> <o:p></o:p></p>
                        </div>
                        <p class="MsoNormal"><o:p> </o:p></p>
                        <div class="MsoNormal" style="text-align:center"
                          align="center">
                          <hr width="100%" size="2" align="center">
                        </div>
                        <p class="MsoNormal"><span
style="font-size:7.5pt;font-family:"Arial",sans-serif;color:gray"><br>
                            This message and any attachments are
                            intended only for the use of the individual
                            or entity to which they are addressed. If
                            the reader of this message or an attachment
                            is not the intended recipient or the
                            employee or agent responsible for delivering
                            the message or attachment to the intended
                            recipient you are hereby notified that any
                            dissemination, distribution or copying of
                            this message or any attachment is strictly
                            prohibited. If you have received this
                            communication in error, please notify us
                            immediately by replying to the sender. The
                            information transmitted in this message and
                            any attachments may be privileged, is
                            intended only for the personal and
                            confidential use of the intended recipients,
                            and is covered by the Electronic
                            Communications Privacy Act, 18 U.S.C.
                            §2510-2521.
                          </span><o:p></o:p></p>
                      </div>
                      <p class="MsoNormal">_______________________________________________<br>
                        Gnso-newgtld-wg mailing list<br>
                        <a href="mailto:Gnso-newgtld-wg@icann.org"
                          target="_blank" moz-do-not-send="true">Gnso-newgtld-wg@icann.org</a><br>
                        <a
                          href="https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg"
                          target="_blank" moz-do-not-send="true">https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg</a><br>
                        _______________________________________________<br>
                        By submitting your personal data, you consent to
                        the processing of your personal data for
                        purposes of subscribing to this mailing list
                        accordance with the ICANN Privacy Policy (<a
                          href="https://www.icann.org/privacy/policy"
                          target="_blank" moz-do-not-send="true">https://www.icann.org/privacy/policy</a>)
                        and the website Terms of Service (<a
                          href="https://www.icann.org/privacy/tos"
                          target="_blank" moz-do-not-send="true">https://www.icann.org/privacy/tos</a>).
                        You can visit the Mailman link above to change
                        your membership status or configuration,
                        including unsubscribing, setting digest-style
                        delivery or disabling delivery altogether (e.g.,
                        for a vacation), and so on.<o:p></o:p></p>
                    </blockquote>
                  </div>
                  <pre style="text-align:center"><hr width="100%" size="2" align="center"></pre>
                  <pre>
Gnso-newgtld-wg mailing list
<a href="mailto:Gnso-newgtld-wg@icann.org" target="_blank" moz-do-not-send="true">Gnso-newgtld-wg@icann.org</a>
<a href="https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg" target="_blank" moz-do-not-send="true">https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg</a><o:p></o:p></pre>
                  <pre style="text-align:center"><hr width="100%" size="2" align="center"></pre>
                  <pre>
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" target="_blank" moz-do-not-send="true">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" target="_blank" moz-do-not-send="true">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.<o:p></o:p></pre>
                </blockquote>
              </div>
            </div>
          </blockquote>
        </div>
      </div>
      <br>
      <hr>
      <font size="1" face="Arial" color="Gray"><br>
        This message and any attachments are intended only for the use
        of the individual or entity to which they are addressed. If the
        reader of this message or an attachment is not the intended
        recipient or the employee or agent responsible for delivering
        the message or attachment to the intended recipient you are
        hereby notified that any dissemination, distribution or copying
        of this message or any attachment is strictly prohibited. If you
        have received this communication in error, please notify us
        immediately by replying to the sender. The information
        transmitted in this message and any attachments may be
        privileged, is intended only for the personal and confidential
        use of the intended recipients, and is covered by the Electronic
        Communications Privacy Act, 18 U.S.C. §2510-2521.
        <br>
      </font>
      <br>
      <fieldset class="mimeAttachmentHeader"></fieldset>
      <pre class="moz-quote-pre" wrap="">_______________________________________________
Gnso-newgtld-wg mailing list
<a class="moz-txt-link-abbreviated" href="mailto:Gnso-newgtld-wg@icann.org">Gnso-newgtld-wg@icann.org</a>
<a class="moz-txt-link-freetext" href="https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg">https://mm.icann.org/mailman/listinfo/gnso-newgtld-wg</a>
_______________________________________________
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a class="moz-txt-link-freetext" href="https://www.icann.org/privacy/policy">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a class="moz-txt-link-freetext" href="https://www.icann.org/privacy/tos">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</pre>
    </blockquote>
  </body>
</html>